Read more
3:18 PM · 4 August 2023

DE30: Stocks wipe out downward momentum ahead of NFP reading!

Carl Zeiss Meditec
Stocks
AFX.DE, Carl Zeiss Meditec AG
-
-
Vonovia
Stocks
VNA.DE, Vonovia SE
-
-
Credit Agricole
Stocks
ACA.FR, Credit Agricole SA
-
-
  • Indices in Europe are losing, but the sheer scale of the sell-off is minima

  • General sentiment has improved somewhat after a series of sell-offs in recent sessions

  • The No. 1 topic of today's session is the NFP report from the US

  • Carl Zeiss Meditec (AFX.DE), Vonovia (VNA.DE) and Credit Agricole (ACA.FR) earnings in market spotlight

European stock markets in this week's final trading session are behaving much better after the wave of sell-offs of recent sessions. Although most indices are trading below yesterday's closing levels, the sheer scale of the declines is virtually imperceptible. 

The key topic of the last session this week will be the very important NFP report from the USA, which will indicate the state of the US labour market, which, let us remind ourselves, is, apart from inflation itself, the most important determinant of any future FOMC decision on interest rates. The report will be released at 14:30, so investors should keep a close eye on how the market will react to this report. 

The mood in Europe improved markedly during this week's last trading session. Very good sentiment currently prevails primarily in the banking, oil and aviation sectors. Source: xStation 5

German DE30 futures remain close to yesterday's closing levels, but it is worth noting that the index attempted today to permanently break above the psychological barrier at 16 000 points. However, this test, at least for the time being, proved unsuccessful and the index returned to the 15 950 point zone. Source: xStation 5

News:

The shares of Carl Zeiss Meditec (AFX.DE) are attempting to make up for the morning's declines due to a drop in EBIT margin to 16.2% against last year's 20.7%. The company additionally lowered its forecast for the 2022/2023 fiscal year in terms of this margin to a range of 17-20% (forecast at the lower end of this range). 

Quotations of the company's shares, D1 interval. Source: xStation 5

Today's session is also not very kind to investors of Vonovia (VNA.DE), whose shares are currently losing more than 3% following the publication of weak quarterly results. 

The company's Q2 loss amounted to €2.1 billion compared to last year's profit of €1.8 billion and it wrote down the value of its real estate holdings by €3 billion due to the weakness of the real estate sector in Germany. Companies in this sector will apply for government assistance in the face of a tough business climate.

As the company's CEO added, an increase in the company's capital is not under consideration at this time.

Quotations of the company's shares, D1 interval. Source: xStation 5

In the banking market, sentiment is improved today mainly by Credit Agricole Bank (ACA.FR), which beat expectations in terms of Q2 2023 results and announced the expansion of its wealth management business through the acquisition of Degroof Petercam for €1.5 billion. The bank's Q2 net profit came in at €2.04 billion against expectations of €1.39 billion, recording a year-on-year increase of 25%. 

Quotations of the company's shares, D1 interval. Source: xStation 5

Major percentage changes in individual companies of the DAX index. Source: Bloomberg Finance L.P.

Information from individual companies in the DAX index. Source: Bloomberg Finance L.P.

 

15 December 2025, 10:49 PM

Daily Summary: Tech sector fears send markets lower

15 December 2025, 9:05 PM

End of Zillow? Google enters another market.

15 December 2025, 6:53 PM

US OPEN: Mild optimism at the start of the week

15 December 2025, 1:50 PM

Sanofi Under Pressure After FDA Delay and Failed Trials

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Join over 2 000 000 investors from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the SCA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the SCA

The financial instruments we offer are risky. XTB is regulated by the DFSA.